Published in Gut on July 01, 1979
Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer (1984) 1.56
Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma. Ann Surg (1988) 0.97
Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1971) 4.40
Acute paracetamol poisoning. Br Med J (1970) 4.14
Possible association between benign hepatomas and oral contraceptives. Lancet (1973) 3.98
Successful treatment of severe paracetamol overdosage with cysteamine. Lancet (1974) 3.83
Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med (1976) 3.60
Oral methionine in the treatment of severe paracetamol (Acetaminophen) overdose. Lancet (1976) 3.20
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet (1977) 3.00
Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med (1970) 2.71
Unexplained hepatitis following halothane. Br Med J (1976) 2.62
Methyldopa liver damage. Br Med J (1974) 2.40
Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology (1974) 2.40
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33
Androgen-induced hepatoma. Lancet (1975) 2.21
Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med (1969) 2.17
Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet (1975) 2.15
Changing pattern of drugs used for self-poisoning. Br Med J (1978) 2.11
Isoniazid-associated hepatitis in 114 patients. Gastroenterology (1975) 2.02
Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology (1977) 1.82
Hepatorenal damage from toluene in a "glue sniffer". Br Med J (1971) 1.82
Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology (1978) 1.80
Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med (1976) 1.63
Liver damage due to methotrexate in patients with psoriasis. Br Med J (1971) 1.62
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy. Tubercle (1971) 1.62
Centrilobular hepatic necrosis and acute renal failure in "solvent sniffers". Ann Intern Med (1970) 1.60
The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies. Postgrad Med J (1978) 1.53
Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med (1977) 1.50
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). Gastroenterology (1978) 1.48
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet (1975) 1.46
Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J (1978) 1.45
Progress in hepatology. Metabolic activation of drugs to toxic substances. Gastroenterology (1975) 1.42
The effect of estrogen on bile formation in the rat. J Clin Invest (1969) 1.37
Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J (1975) 1.36
Isoniazid-associated hepatitis. Report of an outbreak. Am Rev Respir Dis (1972) 1.35
The stimulation and inhibition of hepatic microsomal drug-metabolizing enzymes with special reference to effects of environmental contaminants. Toxicol Appl Pharmacol (1970) 1.32
Liver damage from long-term methyltestosterone. Lancet (1977) 1.25
Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med (1975) 1.23
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology (1977) 1.19
Drug-induced chronic liver disease. Gastroenterology (1977) 1.16
Chronic liver disease and acetaminophen. Ann Intern Med (1977) 1.16
Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology (1977) 1.15
Microfilament dysfunction as a possible cause of intrahepatic cholestasis. Gastroenterology (1975) 1.13
Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet (1978) 1.12
Effects of liver disease on drug disposition in man. Biochem Pharmacol (1976) 1.11
Lactose-fermenting Salmonella indiana from turkeys in Britain. Lancet (1978) 1.09
Determinants of fasting and postprandial serum bile acid levels in healthy man. Am J Dig Dis (1978) 1.08
Diet and toxicity. Br Med Bull (1969) 1.08
The clinical, radiologic, and pathologic characterization of benign hepatic neoplasms. Alleged association with oral contraceptives. Medicine (Baltimore) (1978) 1.06
Rifampicin hepatitis. A clinical and histological study. Lancet (1974) 1.05
Jaundice due to erythromycin estolate. Gastroenterology (1975) 1.05
Methyldopa Hepatitis. A report of six cases and review of the literature. Am J Med (1976) 1.04
Jaundice due to carbimazole. Gut (1975) 1.00
Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of literature. Hum Pathol (1976) 0.99
Allopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction. Arch Intern Med (1978) 0.99
Effects of estrogens on the liver. Gastroenterology (1978) 0.96
Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol (1975) 0.96
Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet (1978) 0.95
Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol (1971) 0.94
Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand A (1977) 0.94
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology (1977) 0.92
Salicylate hepatitis. Gastroenterology (1977) 0.89
Effects of chlorpromazine hydrochloride and its metabolites on Mg2+- and Na+,K+-ATPase activities of canalicular-enriched rat liver plasma membranes. Gastroenterology (1978) 0.87
Asymptomatic liver cell adenomas. Another case of resolution after discontinuation of oral contraceptive use. JAMA (1978) 0.86
Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J (1976) 0.86
Metabolic activation: biochemical basis for many drug-induced liver injuries. Prog Liver Dis (1976) 0.85
Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis. J Clin Pathol (1977) 0.82
Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta Pathol Microbiol Scand A (1975) 0.81
Proper management of hepatic adenoma associated with oral contraceptives. Surg Gynecol Obstet (1977) 0.80
Diphenylhydantoin-induced hepatic necrosis. A case study. Gastroenterology (1976) 0.80
Oxacillin hepatitis. Two patients with liver biopsy, and review of the literature. Am J Med (1978) 0.79
Acetaminophen and liver disease. Ann Intern Med (1978) 0.79
Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases. Am J Dig Dis (1977) 0.79
Structural and functional abnormalities of the liver in psoriasis before and during methotrexate therapy. Br J Dermatol (1972) 0.78
Liver ultrastructure in psoriatics related to methotrexate therapy. 1. A prospective study of findings in hepatocytes from 24 patients before and after methotrexate treatment. Acta Pathol Microbiol Scand A (1977) 0.78
Hepatic metabolism of drugs. Gut (1972) 0.77
Halothane hepatitis: benign resolution of a severe lesion. Ann Intern Med (1978) 0.77
Letter: Aspirin hepatotoxicity. Ann Intern Med (1974) 0.76
Oral contraceptives in acute viral hepatitis. JAMA (1975) 0.76
Cytotoxicity of phenothiazines on Chang liver cells as measured by enzyme leakage. Proc Soc Exp Biol Med (1969) 0.76
Liver pathology in hycanthone hepatitis. Gastroenterology (1978) 0.75
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
The pathology of hepatitis C. Hepatology (1992) 1.92
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet (1975) 1.90
Sex-related differences among 100 patients with alcoholic liver disease. Br Med J (1977) 1.89
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62
Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet (1972) 1.60
Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet (1971) 1.60
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol (1972) 1.50
Halothane hepatitis. Lancet (1978) 1.50
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med (1967) 1.48
Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) (1987) 1.47
Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate. Lancet (1974) 1.46
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Diagnosis of primary cancer of the liver. Br Med J (1971) 1.45
Clinical diagnosis of the Budd-Chiari syndrome. A report of six cases. Am J Med (1967) 1.45
Immunoglobulin-containing cells in the liver. Clin Exp Immunol (1969) 1.44
Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol (1976) 1.43
Histological demonstration of copper and copper-associated protein in chronic liver diseases. J Clin Pathol (1978) 1.42
Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut (1983) 1.40
Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature. Am J Med (1979) 1.39
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology (1981) 1.38
Diagnosis of halothane-related hepatitis. Proc R Soc Med (1975) 1.38
Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut (1983) 1.37
Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet (1980) 1.36
Prognosis of chronic persistent hepatitis. Lancet (1970) 1.35
Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol (1976) 1.35
The serum concentration of the third component of complement beta-1C-beta-1A in liver disease. Gut (1971) 1.33
Presymptomatic Wilson's disease. Lancet (1967) 1.33
Accuracy of computed tomography in diagnosis of fatty liver. Br Med J (1980) 1.32
Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis. Lancet (1971) 1.31
Halothane hepatitis. Gut (1971) 1.31
Primary biliary cirrhosis or sarcoidosis--or both. N Engl J Med (1972) 1.30
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. Lancet (1967) 1.30
Chronic hepatitis. Gut (1974) 1.30
Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. Lancet (1974) 1.29
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Emergency oesophageal transection in uncontrolled variceal haemorrhage. Br J Surg (1973) 1.29
Chronic liver disease and mitochondrial antibodies: a family study. Br Med J (1972) 1.29
The value of percutaneous cholangiography. Br J Surg (1965) 1.28
HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. J Clin Pathol (1980) 1.28
Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet (1976) 1.27
Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology (1981) 1.26
Wilson's disease, presenting as chronic active hepatitis. Gastroenterology (1978) 1.26
Computed tomography for determining liver iron content in primary haemochromatosis. Br Med J (1980) 1.25
Biliary secretory failure in man. The problem of cholestasis. Ann Intern Med (1966) 1.24
Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum (1983) 1.23
Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med (1975) 1.23
A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology (1976) 1.23
A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci (1980) 1.23
Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23
Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med (1979) 1.22
Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis. Gastroenterology (1974) 1.22
The liver in secondary (early) syphilis. N Engl J Med (1971) 1.21
Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology (1982) 1.20